wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35811836-1642B225-AB7E-4F5E-A231-70A85FDB2C03
Q35811836-1642B225-AB7E-4F5E-A231-70A85FDB2C03
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35811836-1642B225-AB7E-4F5E-A231-70A85FDB2C03
Phase III, randomized, double-blind, placebo-controlled, multicenter study of lipegfilgrastim in patients with non-small cell lung cancer receiving myelosuppressive therapy.
P2860
Q35811836-1642B225-AB7E-4F5E-A231-70A85FDB2C03
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35811836-1642B225-AB7E-4F5E-A231-70A85FDB2C03
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
12abbefd7ebf4b6ba0ec3c15ce982c5925b32d3b
P2860
First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study.